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ABSTRACT
Objective: The goal of this project was to develop a
migraine functional measurement instrument, derived
from the World Health Organization International Clas-
siﬁcation of Impairments, Disabilities, and Handicaps
version 2 classiﬁcation system, which focuses on func-
tional outcomes, and is both reliable and valid.
Methods: The Functional Assessment in Migraine
(FAIM) questionnaire was developed using a multistep
approach to ensure the brevity, relevance, reliability, and
validity of items. A test set of 71 Mental Functioning and
50 Activity and Participation items was generated and
administered to migraineurs in the United States and Ger-
many. A subset of 22 Mental Functioning and 28 Activity
and Participation items that rated highly on frequency-
weighted importance and showed strong psychometric
properties was piloted to determine a ﬁnal item set and to
test reliability and validity.
Results: The ﬁnal version of the FAIM included nine
Mental Functioning items measuring the dimensions of
Attention/Thought (5 items) and Perception (4 items),
and a list of 28 Activity and Participation items from
which  respondents  chose  the  ﬁve  items  most  relevant
to their lifestyle. Construct validity analysis of FAIM
dimensions found signiﬁcant positive correlations with
self-reported symptom severity, moderately signiﬁcant
positive correlations with dimensions of the Migraine-
Speciﬁc Quality of Life questionnaire  and no signiﬁcant
correlation with Short Form Health Survey (SF-12) com-
ponent scores.
Conclusion: The FAIM offers physicians a brief and valid
method of measuring the impact of migraine on mental
functioning and activity and participation as deﬁned by
the WHO International Classiﬁcation of Functioning,
Disability, and Health. Additional testing is underway to
assess its responsiveness to change.
Keywords: functional status, ICF, ICIDH-2, migraine,
outcomes.
Introduction
Migraine is a severe and debilitating headache syn-
drome that is characterized by severe headache pain
and symptoms including nausea, vomiting, and sen-
sitivity to light and sound. It has been estimated that
migraine affects 13% of the US population, an esti-
mated 27.9 million Americans over the age of 12
[1]. Migraine is also associated with signiﬁcant
medical expense and loss of productivity. It has been
estimated that the annual direct cost of migraine in
the US is $1 billion [2]. A recent comprehensive
review of migraine literature found that estimates
of direct health-care costs for migraineurs who seek
treatment ranged from $100 to $800 per year
depending on severity. This study also found that
estimates of migraine-related lost work days for
general  migraine  populations  ranged  from  1.9
to 7.4 days and that lost work day equivalents
(adjusted for productivity) ranged from 4.4 to 8.9
[3]. Treatment of migraine adds signiﬁcant expense
to the health-care system, with migraineurs having
direct and indirect medical costs nearly 34% higher
than nonmigraineurs [4].
In recent years, advances have added many
treatment options for migraineurs [5]. Migraine
treatment outcomes, however, are challenging to
measure because of the individual and subjective
Pathak et al.592
nature of headache symptoms. Three primary
approaches have been used in conducting such out-
come studies: 1) symptom-based questionnaires
such as the Henry Ford Hospital Headache Disabil-
ity Inventory and the Pain Behavior Questionnaire;
2) global quality of life instruments such as the
Short Form (SF)-36 Health Survey [6,7]; and 3)
migraine-speciﬁc quality of life instruments such as
the Migraine-Speciﬁc Quality of Life questionnaire
(MSQ) [8,9], Migraine-Speciﬁc Quality of Life
measure [10,11], and 24-Hour Migraine Quality of
Life questionnaire [12]. Although each of these
approaches is valuable in appropriate situations,
none focuses speciﬁcally on the impact of migraine
on functioning, which in turn affects productivity, a
key concern of migraineurs, clinicians, employers,
and health policy decision makers.
This article documents the development of a new
migraine measurement instrument focused solely on
the impact of migraine on functional status using
the International Classiﬁcation of Impairments,
Disabilities, and Handicaps version 2 (ICIDH-2)
developed by the World Health Organization
(WHO). Our goals in creating the Functional
Assessment in Migraine questionnaire (FAIM) were
to develop a patient-reported outcome measure-
ment instrument that 1) is conceptually consistent
within an internationally recognized theoretical
framework, that is, the WHO’s ICIDH-2; 2) is
focused solely on functional outcomes; 3) recog-
nizes the individuality of a migraine’s impact on
functioning activities; 4) has strong psychometric
properties; 5) is validated for use in multiple coun-
tries; 6) does not overlap with clinical measures;
and 7) is brief and readily usable by clinicians.
Methods
Conceptual Model
The conceptual model for the development of this
instrument was the WHO’s ICIDH-2, which has
since been revised and renamed the International
Classiﬁcation of Functioning, Disability, and Health
(ICF). This classiﬁcation system creates a common
language within which researchers can explore
health and health-related status [13]. Researchers in
disciplines including nursing [14], rheumatoid
arthritis [15], and rehabilitation [16] have evaluated
the usefulness of the system or modiﬁcations of the
system in measuring health outcomes with generally
favorable results.
In the conceptual model for ICIDH-2, health
conditions and personal and environmental contex-
tual factors impact three health or health-related
dimensions: 1) Body structure and function—phys-
iological/psychological functioning and anatomical
features; 2) Activity—extent of personal function-
ing; and 3) Participation—extent of interaction with
society. This model expands upon the linear nature
of the original ICIDH proposed in 1980 by allowing
the dimensions to have reciprocal effects on one
another [17]. In practice, it creates a classiﬁcation
and measurement scheme for disability that is inde-
pendent of disease diagnosis and that can be imple-
mented across health-care settings.
This migraine instrument was designed with the
goal of identifying and measuring the “Body Struc-
ture and Function” domains that are most relevant
to migraineurs. The design of the instrument also
measures the “Activity” and “Participation” dimen-
sions by allowing respondents to identify those
activities and interactions that are most relevant to
their personal functioning.
Selection of Items
To select an exhaustive set of items to be tested,
focus group interviews were developed in the
United States and Germany. Review of the focus
group transcripts yielded 262 items for “Body
Structure and Function” and 186 items were iden-
tiﬁed for “Activity” and “Participation” combined.
After removing duplicative and nonspeciﬁc items, a
total of 71 “Body Structure and Function” items
and 50 “Activity and Participation” items were
selected for the ﬁrst draft of the instrument for item
reduction. Each of the “Body Structure and Func-
tion” items was then categorized using the ICF sys-
tem. Because all items retained reﬂected mental
functioning as deﬁned by the taxonomy, the rest of
this document uses the term “Mental Functioning”
as opposed to “Body Structure and Function.
Pretesting
A sample of 153 migraineurs in the United States
and 148 migraineurs in Germany pretested the gen-
erated item list. To be eligible, respondents must
have experienced at least three migraines in the past
12 months and must regularly experience at least
three of the ﬁve International Headache Society
(IHS) symptom criteria for migraines during head-
aches [18]. To ensure consistency of items across the
two nations, back translation of the German instru-
ment was conducted and evaluated. Any discrepan-
cies found were corrected prior to the pretest.
During the pretest phase, each respondent com-
pleted a survey tool including a screening section
assessing eligibility, a background section assessing
migraine symptoms and severity, an item evaluation
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section assessing the frequency of occurrence and
importance of each of the test items, and a demo-
graphic section. A subset of respondents partici-
pated in a debrieﬁng after completing the pretest
instrument to assess the acceptability and under-
standability of the items.
Item Evaluation and Reduction
Samples from the United States and Germany were
analyzed independently. Using the method origi-
nally proposed by Guyatt, each respondent was
asked to identify each item that they felt was a
problem during their migraine attack (Yes or No)
and to then rate the importance of the chosen items
on a 5-point scale (0 = “Not very important” to
4 = “Extremely important”) [19]. Using data from
the pretest sample, the 121 items were ranked by
weighted mean importance, calculated by multiply-
ing the proportion of subjects who identiﬁed the
items as being a problem by the mean importance
score of the item. Thus, the weighted mean impor-
tance scores ranged from 0 to 4. Items with a
weighted mean importance of at least 2.5 in the
overall population or in a subgroup deﬁned by gen-
der, prescription medication use, employment sta-
tus, or severity were considered most relevant for
further consideration. Because we were not seeking
to identify speciﬁc factors or to severely limit
choices in the Activity and Participation dimension,
reduction for Activity and Participation items ended
with the weighted mean importance.
For Mental Functioning items, the next step was
to construct correlation matrices among the remain-
ing items to exclude items measuring the same con-
struct. When correlations of 0.60 or higher were
found between items, the items were reviewed for
their clinical relevance and content. If the items
appeared similar in content, the item with the lower
weighted mean importance was dropped from fur-
ther consideration.
Exploratory principal component factor analysis
with varimax rotation was conducted to identify
orthogonal factors and to determine if the ICF cat-
egorization held as factors in the pretest data. This
method also allowed further item reduction. Items
that loaded highly on only one factor with low load-
ings on other factors were kept for pilot testing.
Pilot Test
Because the factors identiﬁed in the United States
and Germany were largely similar, items generated
from both countries were combined and developed
into a preliminary instrument that was piloted in a
sample of 75 migraineurs in the United States and
83 migraineurs in Germany. Eligibility requirements
were consistent with those in the pretest sample. In
this phase, respondents were asked to evaluate how
much each item impacted their lives within
24 hours of their typical migraine onset on a 7-
point scale from 1 = “Not at all” to 7 = “All of the
time.” Screening, background, and demographic
questions remained the same as in the pretest instru-
ment. A subset of respondents was debriefed after
this phase as well to assess the usability of the
instrument.
Factor Conﬁrmation and Final Item Reduction
Because of the lack of statistical difference in
responses between the US and German pilot data,
these samples were combined for the ﬁnal item
reduction phase. Conﬁrmatory factor analysis was
used to determine how well the identiﬁed ICIDH-2
factors held in pilot data set. Model ﬁt was deter-
mined by looking at three measures of ﬁt used in
structural equation modeling: 1) the c2 test for per-
fect ﬁt; 2) the root-mean-squared error of approxi-
mation (RMSEA); and 3) the non-normed ﬁt index
(NNFI) [20]. The c2 statistic tests the hypothesis
that the model ﬁts the data exactly. An insigniﬁcant
result (P > 0.05) demonstrates that this hypothesis
cannot be rejected and therefore “good” ﬁt is dem-
onstrated. For the RMSEA, values between 0 and
0.05 demonstrate an excellent ﬁt, values greater
than 0.05 but less than 0.08 are considered good,
values greater than 0.08 but less than 0.10 are con-
sidered marginal, and values greater than 1 are con-
sidered poor. For the NNFI, which compares the
proposed model to a null model, values above 0.95
are considered good.
Dimension Development and Evaluation
To assure that simply summing the responses to
items in each scale could create summary scores,
standard summated rating scale evaluation was
conducted. The following characteristics were
assessed: 1) consistency of means and standard
deviations across all items in each factor, thus negat-
ing the need for standardization; 2) linear relation-
ship of each item to its hypothesized dimension as
assessed by item–dimension correlations corrected
for overlap greater than 0.40; and 3) equal contri-
bution of each item to its hypothesized dimension as
measured by equality of item–dimension correla-
tions corrected for overlap [21].
Evaluation of reliability was conducted using a
modiﬁed version of Campbell and Fiske’s Multi-
trait/Multimethod analysis [22]. The Campbell and
Fiske approach is based on a correlation matrix,
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using each measured dimension (multitrait) and
each method used for measuring those traits (mul-
timethod). The off-diagonal elements of the matrix
represent correlations between dimensions and/or
methods, and the diagonal elements represent
internal consistency as measured by Cronbach a.
Because only one method, individual survey, was
used in this study, our calculation will be a multi-
trait/monomethod approach. These analyses were
conducted using the Multitrait Analysis Program
[21].
Construct validity of the dimensions and of the
overall instrument were assessed using three
approaches. First, the FAIM was compared with the
MSQ [9], an existing validated assessment instru-
ment that was administered concurrently with the
FAIM. A correlation matrix relating the ﬁnal FAIM
dimensions and the three dimensions of the MSQ—
Role Restrictive, Role Preventive, and Emotional
Function—were generated. It was hypothesized that
low to moderate correlation would be seen between
all dimensions of the FAIM and the MSQ. Secondly,
the FAIM was correlated with the Physical Compo-
nent Score (PCS-12) and Mental Component Score
(MCS-12) derived from the SF-12, a 12-item gen-
eral health assessment instrument [23]. Because of
the generic nature of the SF-12, it was hypothesized
that correlation would be positive but small. The
third approach evaluated validity based on symp-
tom severity and overall severity. FAIM scores were
correlated with self-reported severity of headache
pain, nausea, vomiting, sensitivity to light, and sen-
sitivity to sound measured on a 7-point scale and
with self-reported functional status measured on a
7-point scale.
Results
Item Categorization
The 71 Mental Functioning items and the 50 Activ-
ity and Participation items developed from the focus
group process were categorized using the ICIDH-2
classiﬁcation system. The ICIDH-2 classiﬁcations
with greatest representation among functioning
items included Emotional Functioning (24 items),
Consciousness (10 items), and Higher Cognitive
Functioning (nine items). ICIDH-2 Activity and
Participation classiﬁcations with the greatest repre-
sentation were Domestic Life (15 items), Work and
Employment (12 items), General Tasks (six items)
and Community, Social and Civic Life (six items).
Pretesting and Initial Item Reduction
A total of 153 US respondents and 148 German
respondents completed the item pretest instrument.
Two US respondents and four German respondents
were excluded because of incomplete or inaccurate
data, leaving a total of 151 respondents in the
United States and 144 respondents in Germany.
Table 1 presents the demographic characteristics of
the pretest samples. US and German samples were
similar in age, gender, and employment status.
Respondents from the United States were more
likely to have education beyond high school and
respondents from Germany were more likely to
have some kind of health insurance.
In the United States, 23 of the Mental Function-
ing items tested had weighted importance values
greater than or equal to 2.5 in either the overall
sample or in a studied subgroup. In Germany, 26
Mental Functioning items reached the threshold.
Correlation matrices were calculated using the
items remaining in each group. In the United States,
two items were dropped because of high correlation
and similar content with higher weighted items. For
example, item A, which read, “I avoid as much con-
tact as possible,” and item B, which read, “I do not
want to be around anyone,” correlated at a level of
0.69. Because the items had weighted importance
levels of 2.52 and 2.77, respectively, the ﬁrst item
was dropped. In Germany three items were dropped
for the same reason.
Table 1 Characteristics of item reduction and pilot samples
Characteristic, n (%)
Item reduction sample Pilot sample 
US
N = 151
Germany
N = 144
US
N = 69
Germany
N = 83
Women 100 (66.2) 103 (71.5) 53 (76.8) 58 (69.9)
Education beyond high school 95 (62.9) 25 (17.4) 47 (68.1) 19 (22.9)
Employed full time 76 (50.3) 55 (38.2) 38 (55.1) 44 (53.7)
Married 65 (43.1) 76 (52.8) 40 (58.0) 40 (48.8)
Insured 117 (77.5) 143 (99.3) 53 (76.8) 83 (100)
Migraine in past 7 days 79 (52.3) 47 (32.6) 37 (53.6) 25 (30.1)
Prescription medication 78 (51.7) 112 (77.8) 30 (43.5) 56 (67.5)
Usually requires bed rest 38 (25.2) 33 (22.9) 16 (23.2) 20 (24.1)
Mean age, years (SD) 37.5 (13.2) 43.3 (13.7) 38.8 (11.2) 41.0 (13.5)
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Factor analysis of the remaining Mental Func-
tioning items was conducted to conﬁrm that items
that had been attributed to given ICIDH-2 factors
loaded accordingly, and to identify the factors of
greatest importance to migraineurs. In the United
States, factor analysis conﬁrmed the presence of
four factors. The ﬁrst was made up of items meas-
uring the ICIDH-2 global factors of Energy and
Sleep. The remaining three measured factors of
Perceptual Functions, Emotional Functioning, and
combined Attention and Thought Functioning. In
the German sample, three factors were identiﬁed.
The ﬁrst factor included items measuring Attention
and Thought Functioning, the second factor
included items measuring Perceptual Functioning,
and the third included items measuring Emotional
Functioning. Table 2 gives deﬁnitions and reliabili-
ties for each factor. In both samples, the identiﬁed
factors showed strong internal reliability with
Cronbach a values ranging from 0.70 to 0.85.
Although the individual items identiﬁed in the
United States and Germany differed, the factor
structures were quite similar. Therefore, it was
decided that the pilot instrument would include all
items identiﬁed in both samples. One additional
item was dropped because of wording issues iden-
tiﬁed during the debrieﬁng session with selected
respondents. This left a ﬁnal set of 22 Mental Func-
tioning items to be piloted.
In the evaluation of Activity and Participation
items, 26 were found to have frequency weighted
importance above 2.0 in the overall or subgroup
data across the two countries. The level was set
lower than the 2.5 used in Mental Functioning to
retain an adequate number of items and to account
for variability in Activity and Participation items
reported by respondents in the two countries. All
items meeting this criterion in either nation were
included in the pilot instrument. It was also deter-
mined that respondents should have the opportu-
nity of adding up to two “other” Activity and
Participation items if the activities that they con-
sidered most important were not included in the
instrument.
Pilot Test and Final Item Reduction
The pilot instrument—including the 22 Mental
Functioning items and 28 Activity and Participation
Table 2 Factor generation from item reduction process
Item number Item Factor loading Standardized alpha if deleted
US
Factor 1 (energy/sleep)
Coefﬁcient alpha
Raw = 0.756
Std = 0.759
I do not have much energy
I am tired
I cannot sleep
0.760
0.702
0.792
0.643
0.725
0.661
Factor 2 (perception)
Coefﬁcient alpha
Raw = 0.764
Std = 0.763
I do not think as quickly
I do not want to hear anything
I cannot tolerate any sensory stimulation
I do not do things with my normal enthusiasm
0.701
0.676
0.696
0.780
0.675
0.754
0.726
0.667
Factor 3 (emotional)
Coefﬁcient alpha
Raw = 0.697
Std = 0.699
I do not want to be around anyone
My tolerance level gets low
I cannot do spontaneous things
0.759
0.766
0.612
0.671
0.527
0.617
Factor 4 
(attention/thought)
Coefﬁcient alpha
Raw = 0.717
Std = 0.724
I cannot concentrate
I cannot focus my eyes—this makes me dizzy
The migraine takes control of my life
I cannot perform properly
0.603
0.682
0.824
0.886
0.513
0.701
0.680
0.827
Germany
Factor 1 
(attention/thought)
Coefﬁcient alpha
Raw = 0.854
Std = 0.858
I cannot perform properly
I cannot focus on issues
I cannot do spontaneous things
I do not think quickly
I cannot organize things well
0.886
0.660
0.853
0.653
0.747
0.827
0.825
0.806
0.857
0.823
Factor 2 (Perception)
Coefﬁcient alpha
Raw = 0.782
Std = 0.786
I just want peace, quiet, and darkness
Sights and sounds around me are overwhelming
I cannot tolerate lights
I need a dark quiet room
0.712
0.723
0.790
0.776
0.739
0.758
0.689
0.747
Factor 3 (emotional)
Coefﬁcient alpha
Raw = 0.747
Std = 0.751
I do not want to be bothered
I totally isolate myself
I avoid as much contact as possible
0.542
0.896
0.658
0.684
0.671
0.647
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items (26 deﬁned items and 2 “other” items) iden-
tiﬁed in item pretest phase—was administered to 69
respondents in the United States and 83 respondents
in Germany. The US sample was 76.8% women and
the German sample was 69.9% women. As in the
item reduction sample, US respondents were signif-
icantly more likely to have post–high school educa-
tion (68.1 vs. 22.9%), and German respondents
were signiﬁcantly more likely to have insurance
(100 vs. 76.8%). Characteristics of this sample are
summarized in Table 1. Data from the pilot tests
were analyzed by country. Because no signiﬁcant
differences were found in items means or psycho-
metric properties, the samples were pooled for the
ﬁnal analysis.
Conﬁrmatory factor analysis was conducted on
the Mental Functioning items to determine if all
items continued to load in the expected manner
based on the functional data collected in the pilot
test. This model, however, did not ﬁt the sample
data. A supplemental exploratory factor analysis
was performed to further reduce the number of
items, which yielded 11 items. The items repre-
sented two factors: “Attention and Thought” and
“Perception.” Conﬁrmatory factor analysis was
then conducted on the reduced set of items, yielding
a marginal ﬁt with a c2 value of 87.08 (df = 43, P <
0.001), an RMSEA of 0.81, and an NNFI of 0.983.
One additional item was removed from each factor
to improve the conceptual ﬁt of the model. Con-
ﬁrmatory factor analysis on the ﬁnal set of nine
items showed an excellent ﬁt with a c2 value of
33.04 (df = 26, P = 0.16), RMSEA of 0.042 (90%
CI 0.00–0.08) and NNFI of 0.99.
As expected, respondents selected a broad variety
of items from the Activity and Participation list.
Although our original research plan called for the
elimination of all items with weighted importance
scores less than 2.5, the Activity and Participation
cut point was decreased to 2.0 because the higher
cut point did not yield a sufﬁcient number of items
from which respondents could choose. No addi-
tional factor identiﬁcation or item reduction was
conducted on the Activity and Participation items
because of the goal of allowing respondents to select
the most personally relevant activities.
Based on the analyses above, the ﬁnal instrument
consists of three dimensions: two Mental Function-
ing dimensions “Attention/Thought” (ﬁve items)
and “Perception” (four items), and an overall
“Activity and Participation” dimension based on
ﬁve items selected by the respondent from a list of
28.
Scaling Properties
Results of scaling property analysis for the two
mental dimensions are presented in Table 3. Item
means and standard deviations within each
dimension were found to be essentially equal. The
Attention/Thought means ranged from 4.53 to
5.21 and standard deviations ranged from 1.32 to
1.75. The Perception means and standard devia-
tions ranged from 5.15 to 5.58 and 1.41–1.67,
respectively. All item total correlations corrected
for overlap exceeded 0.40 within each dimension.
In the Attention/Thought dimension, correlations
ranged from 0.66 to 0.76, and the Perception
dimension correlations ranged from 0.53 to 0.72.
Discriminant validity assessment found that all
items correlated higher with the hypothesized
dimension than with the alternative. For Atten-
tion/Thought, four of the ﬁve loadings were corre-
lated signiﬁcantly higher with their hypothesized
dimension than with the alternative, and in Per-
ception, two of the four items correlated signiﬁ-
cantly higher.
Because the scaling properties support the use of
summated rating scales for the Mental Functioning
Table 3 Scaling properties
Item Mean SD
Correlation with
attention/thought*
Correlation 
with perception*
Correlation
with total*
Attention/thought
Concentration 4.98 1.45 0.71*† 0.53 0.70*
Control of life 4.53 1.75 0.66* 0.51 0.66*
Focus on issues 5.15 1.32 0.76*† 0.47 0.68*
Spontaneity 5.21 1.41 0.73*† 0.53 0.71*
Think quickly 4.87 1.54 0.68*† 0.43 0.62*
Perception
Find peaceful place 5.56 1.52 0.48 0.66*† 0.61*
Light avoidance 5.48 1.61 0.45 0.69*† 0.60*
Sound avoidance 5.58 1.41 0.57 0.72* 0.71*
Interaction avoidance 5.15 1.67 0.47 0.53* 0.56*
*Correlation corrected for overlap by removing the item from the total with which it is correlated.
†Item-scale correlation is signiﬁcantly higher for hypothesized scale than for alternative.
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measures, dimension scores were calculated by sum-
ming the responses in each dimension and trans-
forming these scores to a 0–100 scale, where 100
represents perfect functioning and 0 represents
complete impairment across all scale items. Upon
reviewing these scores, no ﬂoor effects for either
dimension were observed. Minor ceiling effects
were seen for both Attention/Thought and Percep-
tion, with 5.1 and 14.6% of respondents scoring at
the top of each scale, respectively.
For the Activity and Participation dimension,
transformed scores were created using the same
method as in the Attention/Thought and Perception
scales. Because each individual was allowed to
select the items most relevant to them, however,
scaling properties in this dimension were not
assessed.
Reliability
Results of the multitrait/monomethod analysis are
presented in Table 4. All Cronbach a values pre-
sented on the diagonals of the chart exceeded 0.70,
a frequently used standard denoting an acceptable
dimension. Cronbach a values were not calculated
for the Activity and Participation dimensions
because of the heterogeneity of items selected by
respondents. All dimensions correlated signiﬁcantly
with one another.
Validation
Construct validity was assessed by correlating
scores on the three FAIM dimensions with the MSQ
dimensions of Role Restrictive, Role Preventive,
Emotional Function, and the SF-12 dimensions of
Mental Functioning (MCS-12) and Physical Func-
tioning (PCS-12). Table 4 summarizes these results.
Each FAIM dimension correlated signiﬁcantly with
each dimension of the MSQ. The highest correla-
tions were seen between the Attention/Thought
dimension and Role Restrictive and Role Preventive
MSQ dimensions, with correlations of 0.48 and
0.50, respectively. As expected, the lowest correla-
tions were seen with the FAIM and the MSQ emo-
tional dimension. As expected, very low (and
statistically insigniﬁcant) correlations were found
with the MCS-12 or PCS-12.
Construct validity was also measured by com-
paring scores on each FAIM dimension with self-
reported assessments of symptom severity and
functional status. Attention/Thought scores corre-
lated signiﬁcantly with all ﬁve symptom severity
measures: headache pain, nausea, vomiting, sensi-
tivity to light and sensitivity to sound, which were
measured on a 7-point scale, with lower scores
indicating lower symptom problems. These correla-
tions ranged from -0.22 for nausea and vomiting to
-0.34 for headache pain; lower than Attention/
Thought, yet still signiﬁcantly negative, correlations
were found between Perception scores and all symp-
toms except nausea. Activity and Participation
scores correlated signiﬁcantly with all symptoms
except sensitivity to light.
Each FAIM dimension also correlated signiﬁ-
cantly with overall functional status measured on a
7-point scale, with lower scores indicating worse
health. Correlations were found to be 0.45, 0.30,
and 0.29 for Attention/Thought, Perception, and
Activity and Participation, respectively.
Table 4 Reliability and construct validation
Item Mean SD
Attention/thought
correlation
Perception
correlation
Activity and  
participation correlation
Attention/thought 36.7 20.4 (0.87)
Perception 24.4 20.0 0.609* (0.82)
Activity and participation 24.6 19.7 0.444* 0.397 –
Headache pain† 5.81 1.42 -0.337* -0.320* -0.274*
Nausea† 3.95 2.25 -0.220* -0.147‡ -0.173*
Vomiting† 2.97 2.37 -0.221* -0.166* -0.186*
Light sensitivity† 5.21 1.68 -0.262* -0.459* -0.133
Sound sensitivity† 5.41 1.62 -0.294* -0.345* -0.174*
MSQ-RR 37.7 25.4 0.483* 0.422* 0.312*
MSQ-RP 39.8 21.5 0.514* 0.423* 0.387*
MSQ-EF 48.3 27.7 0.381* 0.204* 0.270*
MCS-12 46.2 10.4 0.139 -0.007 0.041
PCS-12 45.0 9.8 0.029 -0.109 0.057
Overall functioning§ 2.79 1.42 0.449* 0.305* 0.286*
*Statistically signiﬁcant correlation (P < 0.05).
†Measured on a 7-point scale, with 1 = mild and 7 = severe.
‡Marginally signiﬁcant correlation (P £ 0.10).
§Measured on a 7-point scale, with 1 = “Not able to function at all” and 7 = “Able to function normally.”
MCS-12, mental component score; MSQ-EF, migraine-speciﬁc quality of life questionnaire–emotional function; MSQ-RP, migraine-speciﬁc quality of life ques-
tionnaire–role preventive; MSQ-RR, migraine-speciﬁc quality of life–role restrictive; PCS-12, physical component score.
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Discussion
In developing the FAIM migraine assessment instru-
ment, a primary goal was the creation of a meas-
urement system that would use the framework put
forth by the WHO in the ICIDH-2. We believed this
to be important for three reasons. First, the ICIDH-
2 considers impairment in terms of functional
impairment, activity limitation, and participation
limitation, all dimensions that migraine is expected
to impact. IHS diagnostic criteria also include
aggravation by physical activity or avoidance of
activity as characteristic of migraine [18]. Second,
because the ICIDH-2 was developed by the WHO
to facilitate international standardization, the
instrument is well-suited for use in multiple nations.
This ﬁrst version was developed based on respond-
ents in the United States and Germany. Finally, the
use of a standardized language helps to allow com-
parability between migraine and other conditions
impacting mental function.
The list of Mental Functioning items generated in
the focus group process included items classiﬁed as
consciousness, orientation, energy, sleep, attention,
thought, emotion, memory, perception, higher-level
cognition, and experience of self and time. It there-
fore appears that migraineurs experience impair-
ment to some extent in most of the ICIDH-2
classiﬁcations. Assessment of the frequency and
importance of impairment, however, found that the
most important factors were attention, thought,
sleep, energy, and emotion. Further piloting and
item reduction limited this list to a combined Atten-
tion/Thought dimension and a Perceptual Function
dimension. In fact, because the Perceptual dimen-
sion is largely reﬂective of items that affect behav-
iors that are symptom-related, researchers may
choose to limit the FAIM to the ﬁve items related to
the Attention/Thought factor and a list of Activity
and Participation items. The results from the item
generation and item reduction phases of this project
support three key ﬁndings: 1) the ICIDH-2 frame-
work can be used in measuring the functional status
of migraineurs; 2) primary migraine effects can be
captured by the impact of migraine on speciﬁc Men-
tal Functioning items; and ﬁnally 3) the use of
exploratory and conﬁrmatory factor analysis can
identify the key dimensions relevant for a simple but
reliable appraisal of migraineurs.
For the Activity and Participation dimension,
rather than attempt to identify a standardized set of
items that could be used for all respondents, we
chose to allow respondents signiﬁcant latitude in
selecting items for measurement. This approach was
chosen because of diversity among individuals in
terms of what activities are most important in their
daily lives. A scale with a limited number of items
may include many items not relevant to some
respondents and may exclude many items that are
important to others. Allowing subjects to select the
items most relevant to them is consistent with the
methodology known as Goal Attainment Scaling
[24], which has been used frequently in the ﬁeld of
mental health [25–27]. Our ﬁndings suggest that
respondents are capable of selecting and rating a
small number of items from an extensive list.
The two Mental Functioning dimensions identi-
ﬁed in this study showed very strong psychometric
properties. Scaling properties to allow for the crea-
tion of a summated rating scale were largely met,
with the exception of some limitations of discrimi-
nant validity. In scales with strong discriminant
validity, each item correlated signiﬁcantly higher
with its hypothesized scale than any alternative
scale; however, in the ﬁnal version of the FAIM
measurement instrument, six of the nine items met
this criterion. For the remaining three items (two
from the Perceptual factor and one from Attention/
Thought), correlations were higher on the hypoth-
esized dimension, but not statistically signiﬁcant.
The FAIM measurement instrument showed
good convergent validity when compared with
symptom severity, self-reported functional impair-
ment, and an alternative migraine-speciﬁc measure-
ment instrument. Signiﬁcant correlations were not
found with the MCSs or PCSs generated from the
SF-12. This was not unexpected. Although the SF-
36, the parent instrument of the SF-12, has been
shown to discriminate between persons with
migraines and those without [6,7], it has been found
to be less responsive than migraine-speciﬁc instru-
ments [9,10,28]. Because of this, it has been sug-
gested that general health-related quality of life
instruments like the SF-36 are better suited to
population description than for assessment of treat-
ment response [28]. Unlike the SF-12 or SF-36, the
FAIM focuses solely on functioning and does not
consider emotional impact, a major component of
the SF-12. Given the difference of focus and lack of
speciﬁcity, the lack of correlation was in the
expected direction.
As with all studies, several limitations are present
in this study. First, convenience samples were used
in both the ﬁrst and second phases of item reduction
and piloting. Second, the limited sample size in the
pilot sample required that the same data be used in
the item reduction and in the conﬁrmatory factor
analysis. When conducting such analysis, it is opti-
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mal to split data into a developmental data set and
a validation data set. Further analysis will be needed
on an independent data set to conﬁrm the results of
the conﬁrmatory factor analysis. Finally, the meth-
odology of the study presented here does not allow
for the assessment of the test-retest reliability of the
instrument or the responsiveness of the instrument
to changes in health status.
Conclusion
The FAIM migraine measurement instrument
offers migraine outcomes researchers a new method
for measuring functional status associated with
migraine. It can be administered as a 9-item tool to
measure dimensions of Attention/Thought and Per-
ception, with an Activity and Participation item list
to allow respondents to identify ﬁve additional
items of personal relevance. Researchers who are
doing clinical evaluation along with the functional
assessment can omit the Perception items, creating
an even briefer tool. The FAIM is unique because it
is built within the framework of the ICIDH-2, and
because it focuses solely on functioning issues rather
than on symptoms or emotional impact. Additional
research is under way to determine if the validity
evidenced in this study is augmented by test-retest
reliability and responsiveness.
Source of ﬁnancial support: Pﬁzer Inc. funded this project.
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